Camptothecin loaded poly(ε-caprolactone)nanofibers via one-step electrospinning and their cytotoxicity impact

Colloids and Surfaces A: Physicochemical and Engineering Aspects

Volumn 431, Issue , 2013, Pages 1-8

  Amna, Touseef ^a   Barakat, Nasser A M ^a   Hassan, M Shamshi ^a   Khil, Myung Seob ^a   Kim, Hak Yong ^a  

^a Chonbuk National University   (South Korea)

Author keywords

Camptothecin; Cytotoxicity; Electrospinning; PCL nanofibers

Indexed keywords

BODY FLUIDS; DIFFERENTIAL SCANNING CALORIMETRY; ELECTROSPINNING; FIELD EMISSION MICROSCOPES; LIQUID CHROMATOGRAPHY; MASS SPECTROMETRY; NANOFIBERS; PHOTOELECTRONS; SOL-GEL PROCESS; SOL-GELS; THERMOGRAVIMETRIC ANALYSIS; ULTRAVIOLET VISIBLE SPECTROSCOPY; X RAY DIFFRACTION; X RAY PHOTOELECTRON SPECTROSCOPY;

CAMPTOTHECIN (CPT); CHEMOTHERAPEUTIC AGENTS; ELECTROSPINNING PROCESS; FIELD EMISSION SCANNING ELECTRON MICROSCOPY; LIQUID CHROMATOGRAPHY - MASS SPECTROMETRIES; PCL NANOFIBERS; PHYSICO-CHEMICAL CHARACTERIZATION; UV-VISIBLE SPECTROSCOPY;

CYTOTOXICITY;

CAMPTOTHECIN; NANOFIBER; POLYCAPROLACTONE;

ARTICLE; CELL VIABILITY; CONTROLLED STUDY; CYTOTOXICITY; DIFFERENTIAL SCANNING CALORIMETRY; DRUG RELEASE; DRUG UPTAKE; ELECTROSPINNING; FIELD EMISSION SCANNING ELECTRON MICROSCOPY; IN VITRO STUDY; LIQUID CHROMATOGRAPHY; PHYSICAL CHEMISTRY; PRIORITY JOURNAL; THERMOGRAVIMETRY; ULTRAVIOLET SPECTROSCOPY; X RAY DIFFRACTION; X RAY PHOTOELECTRON SPECTROSCOPY;

EID: 84877880019     PISSN: 09277757     EISSN: 18734359     Source Type: Journal    
DOI: 10.1016/j.colsurfa.2013.04.026     Document Type: Article

References (35)

1. Hertzberg R.P., Caranfa M.J., Hecht S.M. On the mechanism of topoisomerase I inhibition by camptothecin: evidence for binding to an enzyme-DNA complex. Biochemistry 1989, 28:4629-4638.
2. Dancey J., Eisenhauer E.A. Current perspectives on camptothecin in cancer treatment. Br. J. Cancer 1996, 74:327-338.
3. Potmesil M., Pinedo H.M. Camptothecins New Anticancer Agents 1995, CRC Press, Boca Raton.
4. Takimoto C.H., Wright J., Arbuck S.G. Clinical applications of the camptothecins. Biochim. Biophys. Acta 1998, 1400:107-119.
5. Oberlies N.H., Kroll D.J. Camptothecin and taxol: historic achievements in natural products research. J. Nat. Prod. 2004, 67:129-135.
6. Li S.Y., Adair K.T. Camptotheca acuminata Decaisne, Xi Shu: A Promising Antitumor and AntiViral Tree for the 21st Century, Henry M. Rockwell Monograph 1994, Stephen F. Austin State University, Nacogdoches, TX.
7. Wall M.E., Wani M.C., Cook C.E., Palmer K.H., McPhail A.T., Sim G.A. Plant antitumor agents. I. The isolation and structure of camptothecin, a novel alkaloidal leukemia and tumor inhibitor from Camptotheca accuminata. J. Am. Chem. Soc. 1966, 88:3888-3890.
8. Fassberg J., Stella V.J. A kinetic and mechanistic study of the hydrolysis of camptothecin and some analogues. J. Pharm. 1992, 81:676-684.
9. Chourpa I., Millo J.M., Sockalingum G.D., Riou J.F., Manfait M. Kinetics of lactone hydrolysis in antitumor drugs of camptothecin series as studied by fluorescence spectroscopy. Biochim. Biophys. Acta 1998, 1379:353-366.
10. Venditto V.J., Simanek E.E. Cancer therapies utilizing the camptothecin: a review of in vivo literature. Mol. Pharm. 2010, 7:307-349.
11. Lalloo A., Chao P.Y., Hu P.D., Stein S., Sinko P.J. Pharmacokinetic and pharmacodynamic evaluation of a novel in situ forming poly(ethylene glycol)-based hydrogel for the controlled delivery of the camptothecins. J. Control. Release 2006, 112:333-342.
12. Zhang L.Y., Yang M., Wang Q., Li Y., Guo R., Jiang X.Q. 10-Hydroxycamptothecin loaded nanoparticles: preparation and antitumor activity in mice. J. Control. Release 2007, 119:153-162.
13. Torchilin V.P. Multifunctional nanocarriers. Adv. Drug Deliv. Rev. 2006, 58:1532-1555.
14. Wang K., He Q., Yan X., Cui Y., Qi W., Li D., Li J.B. Encapsulated photosensitive drugs by biodegradable microcapsules to incapacitate cancer cells. J. Mater. Chem. 2007, 17:4018-4021.
15. Gao L., Cui Y., He Q., Yang Y., Fei J., Li J.B. Selective recognition of co-assembled thrombin aptamer and docetaxel on mesoporous silica nanoparticles against tumor cell proliferation. Chem. Eur. J. 2011, 17:13170-13174.
16. Gao L., Fei J., Zhao J., Cui W., Cui Y., Li J.B. pH- and redox-responsive polysaccharide-based microcapsules with autofluorescence for biomedical applications. Chem. Eur. J. 2012, 18:3185-3192.
17. Chong E.J., Phan T.T., Lim I.J., Zhang Y.Z., Bay B.H., Ramakrishna S., Lim C.T. Evaluation of electrospun PCL/gelatin nanofibrous scaffold for wound healing and layered dermal reconstitution. Acta Biomater. 2007, 3:321-330.
18. Li W.J., Tuli R., Okafor C., Derfoul A., Danielson K.G., Hall D.J., Tuan R.S. A three-dimensional nanofibrous scaffold for cartilage tissue engineering using human mesenchymal stem cells. Biomaterials 2005, 26:599-609.
19. Sinha V.R., Bansal K., Kaushik R., Trehan A. Poly-caprolactone microspheres and nanospheres: an overview. Int. J. Pharm. 2004, 278:1-23.
20. Dan Li, Younan Xia Fabrication of titania nanofibers by electrospinning. Nano Lett. 2003, 3:555-560.
21. Xie J., Li X., Xia Y. Putting electrospun nanofibers to work for biomedical research. Macromol. Rapid Commun. 2008, 29:1775-1792.
22. Yaffe D., Saxel O. Serial passaging and differentiation of myogenic cells isolated from dystrophic mouse muscle. Nature 1977, 270:725-727.
23. Mishra A., Tripathy S.K., Wahab R., Jeong S.H., Hwang I., Yang Y.B., Kim Y.S., Shin H.S., Yun S.I. Microbial synthesis of gold nanoparticles using the fungus Penicillium brevicompactum and their cytotoxic effects against mouse mayo blast cancer C2C12 cells. Appl. Microbiol. Biotechnol. 2011, 92:617-630.
24. Hammud H.H., Nemer G., Sawma W., Touma J., Barnabe P., Mouglabey Y.B., Ghannouma A., Hajjar J.E., Usta J. Copper-adenine complex, a compound, with multi-biochemical targets and potential anti-cancer effect. Chem. Biol. Interact. 2008, 173:84-96.
25. Amna T., Puri S.C., Verma V., Sharma J.P., Khajuria R.K., Musarat J., Spiteller M., Qazi G.N. Bioreactor studies on the endophytic fungus Entrophospora infrequens for the production of an anticancer alkaloid camptothecin. Can. J. Microbiol. 2006, 52:189-196.
26. http://www.lasurface.com/database/elementxps.php.
27. Hatefi A., Amsden B. Camptothecin delivery methods. Pharm. Res. 2002, 19:1389-1399.
28. Shenderova A., Burke T.G., Schwendeman S.P. Stabilization of 10-hydroxycamptothecin in poly(lactide-co-glycolide) microsphere delivery vehicles. Pharm. Res. 1997, 14(10):1406-1414.
29. Cortesi R., Esposito E., Maietti A., Menegatti E., Nastruzzi C. Int. J. Pharm. 1997, 159:95-103.
30. Kunii R., Onishi H., Machida Y. Preparation and antitumor characteristics of PLA/(PEG-PPG-PEG) nanoparticles loaded with camptothecin. Eur. J. Pharm. Biopharm. 2007, 67:9-17.
31. Davis M.E. Design and development of IT-101, a cyclodextrin containing polymer conjugate of camptothecin. Adv. Drug Deliv. Rev. 2009, 61:1189-1192.
32. Huang Z., Hua S., Yang Y., Fang J. Development and evaluation of lipid nanoparticles for camptothecin delivery: a comparison of solid lipid nanoparticles, nanostructured lipid carriers, and lipid emulsion. Acta Pharmacol. Sinica 2008, 9:1094-1102.
33. Barrada M., Serreqi A., Dabbarh F., Owusu A., Gupta A., Lehnert S. A novel nontoxic camptothecin formulation for cancer chemotherapy. Biomaterials 2005, 26:2115-2120.
34. Storm P.B., Moriarity J.L., Tyler B., Burger P.C., Brem H., Weingart J. Polymer delivery of camptothecin against 9L gliosarcoma: release, distribution, and efficacy. J. Neurooncol. 2002, 56:209-217.
35. Verreck G., Chun I., Rosenblatt J., Peeters J., Dijck A.V., Mensch J., Noppe M., Brewster M.E. Incorporation of drugs in an amorphous state into electrospun nanofibers composed of a water-insoluble, non-biodegradable polymer. J. Control. Release 2003, 92:349-360.